MedTrace Logo

Glycemic Response to Oral Nutrition Supplements

NCT02612675 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 13

Last updated 2015-11-24

No results posted yet for this study

Summary

This will be a randomized, cross-over study of two oral nutrition supplements in individuals with Type 2 Diabetes.

Conditions

Interventions

OTHER

ONS

Sponsors & Collaborators

  • Société des Produits Nestlé (SPN)

    lead INDUSTRY

Principal Investigators

  • Sherwyn Schwartz, MD · Diabetes & Glandular Disease Clinic, PA

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2013-02-28
Completion
2013-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02612675 on ClinicalTrials.gov